S3188119th CongressWALLET

Biomanufacturing Excellence Act of 2025

Sponsored By: Senator Sen. Coons, Christopher A. [D-DE]

Introduced

Summary

National Biopharmaceutical Center of Excellence would be created inside the National Institute of Standards and Technology to accelerate U.S. biopharmaceutical manufacturing and cut reliance on foreign supply chains. It would promote manufacturing innovation, share best practices, enable public-private collaboration, and support worker training to move lab discoveries into commercial production.

Show full summary
  • U.S. manufacturers and biotech firms: Would gain access to flexible, affordable development infrastructure to prove scale-up and improve chances of commercializing new medicines.
  • Workers and training programs: Would receive support for hands-on training to operate advanced biotechnology tools and build sector talent.
  • Public health, agriculture, and defense: Would benefit from stronger domestic manufacturing capacity that the bill ties to better treatment options, food resilience, and military capabilities.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

National Biopharmaceutical Center and Funding

This bill would direct NIST to fund and pick one non‑federal group to run a National Biopharmaceutical Manufacturing Center of Excellence. It would authorize $120,000,000 for fiscal year 2026 to support the Center. The Director would solicit applications and must award a grant or agreement within 180 days of enactment. The Center could use funds for building facilities, research to scale drug manufacturing, and workforce training. The Center would need intellectual property rules before starting and must send reports to Congress at set timelines.

Free Policy Watch

You just read the policy. Now see what it costs you.

Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.

Pick a topic to get started

Sponsors & CoSponsors

Sponsor

Sen. Coons, Christopher A. [D-DE]

DE • D

Cosponsors

  • Sen. Budd, Ted [R-NC]

    NC • R

    Sponsored 11/18/2025

  • Sen. Padilla, Alex [D-CA]

    CA • D

    Sponsored 3/11/2026

  • Sen. Young, Todd [R-IN]

    IN • R

    Sponsored 3/11/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation

Take It Personal

Get Your Personalized Policy View

Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in